This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
In a landmark move for the pharmaceutical industry, Novo Nordisk has announced a strategic partnership with OpenAI. The collaboration aims to integrate advanced artificial intelligence across the company
Tevogen Bio reveals major performance updates to its PredicTcell AI platform, achieving a 92% recall rate and expanding its proprietary database to 655 million peptide sequences to accelerate immunothera
The tech giant has released the new large language model to foster its drug discovery push.
